Search Results 391-400 of 17108 for Enterostatin

  1. A Registry for Participants with Cirrhosis Who Achieve a Sustained Virologic Response Following Treatment with a Sofosbuvir-Based Regimen without Interferon for Chronic Hepatitis C Infection - Mayo Clinic

    About this study. This Registry will enroll cirrhotic participants with or without decompensated liver disease who have achieved a sustained virologic ...

  2. Pharmacogenomics: Your Own Prescription - Mayo Clinic

    Each person's genetic code is unique. Researchers focused on pharmacogenomics at Mayo Clinic are working to understand how these tiny DNA variations cause ...

  3. A Study Of Self Measured Blood Pressure - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  4. NSAIDS Archives - Mayo Clinic News Network

  5. Neuroendocrine tumors - Doctors and departments - Mayo Clinic

    Learn about the types of tumors that make up this group of rare cancers. Find out about symptoms, causes, diagnosis and treatments.

  6. Pilot Open-Label Trial Of Resistant Potato Starch In Patients With Cirrhosis And Overt Hepatic Encephalopathy - Mayo Clinic

    From this study, we will be able to understand the influence of resistant potato starch on the gut microbiome and SCFA production, thought to be an important ...

  7. Randomized, Double Blind, Placebo-controlled Phase 2 Study In Adults With Celiac Disease - Mayo Clinic

    This study is a randomized, double-blind, placebo controlled clinical study to assess the efficacy, safety, pharmacokinetics (PK) and pharmacodynamics (PD) of ...

  8. Neuroendocrine tumors - Doctors and departments - Mayo Clinic

    Learn about the types of tumors that make up this group of rare cancers. Find out about symptoms, causes, diagnosis and treatments.

  9. Study of CG0070 Given in Combination With Pembrolizumab, in Non Muscle Invasive Bladder Cancer, Unresponsive to Bacillus Calmette-Guerin - Mayo Clinic

    Study of CG0070 Given in Combination With Pembrolizumab, in Non Muscle Invasive Bladder Cancer, Unresponsive to Bacillus Calmette-Guerin · Share · Facebook ...

  10. An Open-Label Study of XOMA 358 in Patients With Hypoglycemia After Gastric Bypass Surgery - Mayo Clinic

    The purpose of this study is to evaluate the safety and clinical pharmacology of XOMA 358 in patients with hypoglycemia after gastric bypass surgery.